Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older, but under 80 years old, who have been diagnosed with asthma for at least 6 months
- People whose asthma is classified as severe under the 2024 GINA guidelines, meaning asthma that remains uncontrolled — with frequent symptoms or flare-ups — even while using high-dose inhaled steroid inhalers combined with long-acting reliever inhalers, or whose symptoms worsen when those medications are slightly reduced
- People who are willing to take part in a thorough, multi-step assessment process and have signed a consent form to participate
- People who are able to attend follow-up appointments over a 6-month period as required by the study
Who may not be able to join:
- People who have other serious lung diseases that cause damage to lung tissue, such as severe bronchiectasis or tuberculosis
- People who have had chest or abdominal surgery within the past 3 months
- People who have had eye surgery within the past 3 months
- People who have had a heart attack within the past 3 months
- People who are currently receiving treatment for tuberculosis
- People who are pregnant or breastfeeding
- People who have taken a type of antibiotic called a macrolide within the 4 weeks before the screening period
- People who have received certain targeted asthma biologic treatments (anti-IgE, anti-IL-5, or anti-IL-5R therapies) within the 4 weeks before the screening period
- People who have been using a specific combination of three inhaler medications — an inhaled steroid, a long-acting reliever, and a long-acting anticholinergic — for the 4 weeks before the screening period
- People who have a known allergy to macrolide antibiotics
- People whose heart trace (ECG) shows a specific electrical timing measurement called QTc interval that is greater than 480 milliseconds
- People who are taking medications that interact with the antibiotic azithromycin in ways that could affect heart rhythm or worsen existing heart electrical abnormalities (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8613601234681
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes from baseline in asthma quality of life score (AQLQ) at 6 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.